These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 5348227)
21. [Debate on drug discount and unnecessary prescriptions]. Lakartidningen; 1975 Dec; 72(50):4942. PubMed ID: 1195935 [No Abstract] [Full Text] [Related]
22. How many antibiotic prescriptions are unsubsidised in New Zealand? Norris P; Funke S; Becket G; Ecke D; Reiter L; Herbison P N Z Med J; 2006 May; 119(1233):U1951. PubMed ID: 16680168 [TBL] [Abstract][Full Text] [Related]
23. Gender differences in drug use and expenditures in a privately insured population of older adults. Correa-de-Araujo R; Miller GE; Banthin JS; Trinh Y J Womens Health (Larchmt); 2005; 14(1):73-81. PubMed ID: 15692281 [TBL] [Abstract][Full Text] [Related]
24. [Open letter to minister of health. Toad medicine]. Erdmann E Krankenpfl J; 2003; 41(4-6):110-1. PubMed ID: 12929321 [No Abstract] [Full Text] [Related]
25. [Evaluation of the examination results in pharmacy prescriptions from the Erfurt district]. Sicker P Pharm Prax; 1970; 8():171-6. PubMed ID: 5508932 [No Abstract] [Full Text] [Related]
26. [Legal boundaries of negative and positive lists]. Arndt M Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):630-2. PubMed ID: 9527457 [TBL] [Abstract][Full Text] [Related]
27. [Suggestion for the relief of personal in a pharmacy in dispensing compulsory prescriptions of ready made drug preparations]. Lüdecke L Pharm Prax; 1971 May; 5():118. PubMed ID: 5562138 [No Abstract] [Full Text] [Related]
29. Big pluses--and minuses--of electronic prescribing. Grandinetti D Med Econ; 1998 Oct; 75(21):48-52. PubMed ID: 10186298 [No Abstract] [Full Text] [Related]
30. The cost of drugs: a policy conundrum of global proportions. Barry DR; Romig B N C Med J; 2003; 64(6):287-8. PubMed ID: 14983620 [No Abstract] [Full Text] [Related]
31. [Collective fines for over-prescription? A German model for reduced use of antibiotics]. Kamme C; Mölstad S Lakartidningen; 1994 Nov; 91(47):4366, 4369-71. PubMed ID: 7808143 [No Abstract] [Full Text] [Related]
32. The professional fee--why and how? Myers MJ Am J Pharm Sci Support Public Health; 1968; 140(4):101-19. PubMed ID: 5678242 [No Abstract] [Full Text] [Related]
33. ["Profiles" and men]. Leger L Presse Med (1893); 1971 May; 79(27):1263. PubMed ID: 5556796 [No Abstract] [Full Text] [Related]
34. [Organization of provision of medical and technical laboratory products by the pharmaceutical services]. Görtz D Pharmazie; 1972 Oct; 27(10):Suppl 10:224-3. PubMed ID: 4636483 [No Abstract] [Full Text] [Related]
35. Seniors' prescription drug cost inflation and cost containment: evidence from British Columbia. Morgan SG; Agnew JD; Barer ML Health Policy; 2004 Jun; 68(3):299-307. PubMed ID: 15113641 [TBL] [Abstract][Full Text] [Related]
36. Rx fee in Utah rises if drug quantity extends beyond 30 days. Pharm Times; 1983 Sep; 49(9):32-3. PubMed ID: 10262970 [No Abstract] [Full Text] [Related]
37. [Current problems of drug supply]. Nord D Fortschr Med; 1979 Apr; 97(15):683-4. PubMed ID: 456967 [No Abstract] [Full Text] [Related]
38. Access to Medicare Part D gap coverage more scarce in 2007. Consult Pharm; 2007 Jan; 22(1):60-1. PubMed ID: 17380599 [No Abstract] [Full Text] [Related]
39. Moral hazard and prescription medicine use in Australia--the patient perspective. Doran E; Robertson J; Henry D Soc Sci Med; 2005 Apr; 60(7):1437-43. PubMed ID: 15652677 [TBL] [Abstract][Full Text] [Related]
40. [Use of computers in evaluation of adequacy in pharmacotheray]. Kubát K; Stika L; Nekvinda V Cas Lek Cesk; 1971 Jul; 110(31):721-6. PubMed ID: 5564714 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]